These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 27053634)

  • 1. Lymphomatoid papulosis type D in a fingolimod-treated multiple sclerosis patient.
    Matoula T; Nikolaou V; Marinos L; Katsavos S; Nasis G; Economidi A; Karampidou K; Stratigos A; Antoniou C
    Mult Scler; 2016 Oct; 22(12):1630-1631. PubMed ID: 27053634
    [No Abstract]   [Full Text] [Related]  

  • 2. Lymphomatoid papulosis: A cutaneous lymphoproliferative disorder in a patient on fingolimod for multiple sclerosis.
    Samaraweera AP; Cohen SN; Akay EM; Evangelou N
    Mult Scler; 2016 Jan; 22(1):122-4. PubMed ID: 26219664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymphomatoid papulosis and fingolimod-A new connection?
    Cohen V; Saber M; Provost N; Friedmann D
    Mult Scler; 2016 Oct; 22(12):1629-1630. PubMed ID: 26993118
    [No Abstract]   [Full Text] [Related]  

  • 4. A Case of cutaneous large B-cell lymphoma during treatment of multiple sclerosis with fingolimod.
    Stitt DW; Boes CJ; Flanagan EP; Howard MT; Colgan JP
    Mult Scler Relat Disord; 2018 Jan; 19():115-117. PubMed ID: 29190574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tattoos and coincidental skin conditions: the example of lymphomatoid papulosis.
    Kluger N
    Br J Dermatol; 2014 Dec; 171(6):1561. PubMed ID: 24841722
    [No Abstract]   [Full Text] [Related]  

  • 6. Lymphomatoid papulosis and FK 506.
    Siddiqui MA; Sullivan S; al-Mofadhi AM
    Int J Dermatol; 1997 Mar; 36(3):202-5. PubMed ID: 9159004
    [No Abstract]   [Full Text] [Related]  

  • 7. Pyoderma gangrenosum responding to ciclosporin without adverse effects in a patient with lymphomatoid papulosis.
    Busick TL; Bennett DD; Cohen JB
    Clin Exp Dermatol; 2010 Dec; 35(8):918-9. PubMed ID: 20456406
    [No Abstract]   [Full Text] [Related]  

  • 8. Superficial spreading malignant melanoma in a patient on fingolimod therapy for multiple sclerosis.
    Haebich G; Mughal A; Tofazzal N
    Clin Exp Dermatol; 2016 Jun; 41(4):433-4. PubMed ID: 26577239
    [No Abstract]   [Full Text] [Related]  

  • 9. Development of a primary cutaneous CD30(+) anaplastic large-cell T-cell lymphoma during treatment of multiple sclerosis with fingolimod.
    Papathemeli D; Gräfe R; Hildebrandt U; Zettl UK; Ulrich J
    Mult Scler; 2016 Dec; 22(14):1888-1890. PubMed ID: 27207455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD30-positive lymphoproliferative disorder in a red tattoo: regional lymphomatoid papulosis type C or pseudolymphoma?
    Haus G; Utikal J; Geraud C; Goerdt S; Leverkus M
    Br J Dermatol; 2014 Sep; 171(3):668-70. PubMed ID: 24689991
    [No Abstract]   [Full Text] [Related]  

  • 11. Type B lymphomatoid papulosis.
    Bouhamidi A; Hassam B
    Pan Afr Med J; 2018; 30():138. PubMed ID: 30374384
    [No Abstract]   [Full Text] [Related]  

  • 12. Severe rebound after withdrawal of fingolimod treatment in patients with multiple sclerosis.
    Gündüz T; Kürtüncü M; Eraksoy M
    Mult Scler Relat Disord; 2017 Jan; 11():1-3. PubMed ID: 28104247
    [No Abstract]   [Full Text] [Related]  

  • 13. Melanoma during fingolimod treatment for multiple sclerosis.
    Velter C; Thomas M; Cavalcanti A; Bastien M; Chochon F; Lubetzki C; Routier E; Robert C
    Eur J Cancer; 2019 May; 113():75-77. PubMed ID: 30986706
    [No Abstract]   [Full Text] [Related]  

  • 14. Lymphomatoid papulosis in a patient treated with adalimumab for juvenile rheumatoid arthritis.
    Park JH; Lee J; Lee JH; Lee DY; Koh EM
    Dermatology; 2012; 225(3):259-63. PubMed ID: 23257839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fingolimod (Gilenya) and melanoma.
    Robinson CL; Guo M
    BMJ Case Rep; 2016 Dec; 2016():. PubMed ID: 28003234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A lymphomatoid papule, but not lymphomatoid papulosis!
    McCalmont TH; LeBoit PE
    Am J Dermatopathol; 2000 Apr; 22(2):188-90. PubMed ID: 10770444
    [No Abstract]   [Full Text] [Related]  

  • 17. [Fingolimod].
    Hashi Y; Kondo T
    Nihon Rinsho; 2015 Sep; 73 Suppl 7():205-11. PubMed ID: 26480701
    [No Abstract]   [Full Text] [Related]  

  • 18. Emergence of lymphomatoid papulosis during treatment with brentuximab vedotin.
    Mansoor N; McKenna L; Molloy O; Smyth E; Flavin R; Ryan C; Quinn J; Roche M
    Int J Dermatol; 2020 Sep; 59(9):e332-e334. PubMed ID: 32578212
    [No Abstract]   [Full Text] [Related]  

  • 19. Bullous lymphomatoid papulosis.
    Sureda N; Thomas L; Bathelier E; Balme B; Depaepe L; Dalle S
    Clin Exp Dermatol; 2011 Oct; 36(7):800-1. PubMed ID: 21575041
    [No Abstract]   [Full Text] [Related]  

  • 20. [Lymphomatoid papulosis type C with weak expression of TCRγ: report of a case].
    Feng L; Xie J; Huang W; Zhang Y; Zhang H; Zhou X
    Zhonghua Bing Li Xue Za Zhi; 2015 Aug; 44(8):608-9. PubMed ID: 26705189
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.